調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023

肝炎検査ソリューション・診断の世界市場予測（～2023年）

◆タイトル：Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023
◆商品コード：MAM-MD-6643
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年10月2日
◆ページ数：113
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥751,450	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥884,450	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,083,950	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、肝炎検査ソリューション・診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、疾患別（B型肝炎、HCV、HAV、HDV）分析、技術別（ELISA、RDT、PCR、転写増幅法）分析、エンドユーザー別（病院、診断ラボ、血液バンク、介護施設）分析、肝炎検査ソリューション・診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・肝炎検査ソリューション・診断の世界市場：市場インサイト
・肝炎検査ソリューション・診断の世界市場：市場概観/市場動向
・肝炎検査ソリューション・診断の世界市場：疾患別（B型肝炎、HCV、HAV、HDV）分析/市場規模
・肝炎検査ソリューション・診断の世界市場：技術別（ELISA、RDT、PCR、転写増幅法）分析/市場規模
・肝炎検査ソリューション・診断の世界市場：エンドユーザー別（病院、診断ラボ、血液バンク、介護施設）分析/市場規模
・肝炎検査ソリューション・診断のアジア市場規模予測
・肝炎検査ソリューション・診断のヨーロッパ市場規模予測
・肝炎検査ソリューション・診断のアメリカ市場規模予測
・肝炎検査ソリューション・診断の世界市場動向
・肝炎検査ソリューション・診断の世界市場：競争状況
・肝炎検査ソリューション・診断の世界市場：関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The global hepatitis test solution/diagnosis market is projected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period. This market is primarily driven by factors such as the high burden of hepatitis worldwide, increasing number of blood transfusions and donations, benefits offered by PoC instruments & kits, and awareness initiatives. Emerging markets such as China, India, Brazil, and Africa are expected to offer lucrative growth opportunities for the players in this market. However, the high cost of NAT tests and a lack of mandate for NAT in developing countries are expected to restrain the growth of this market during the forecast period.
The ELISA segment is expected to account for the largest share of the global hepatitis test solution/diagnosis market, by technology. The large share of ELISA is mainly driven by the wide acceptance of this test in clinical practices to diagnose hepatitis. Rapid diagnostics test segment is expected to register the highest CAGR during the forecast period. High growth of rapid diagnostics test segment can be attributed to the low cost of this test type, its high analytical sensitivity, and its ability to detect all known 11 subtypes of HBsAg.

The hospital and diagnostics laboratories segment is expected to account for the largest share of hepatitis test solution/diagnosis market, by end user, in 2018 and is expected to register the highest CAGR during the forecast period. This can primarily be attributed to the growing patient population, increase in Medicare reimbursement for clinical tests performed in hospitals, and the emergence of advanced diagnostic tests.

Geographically, the hepatitis test solution/diagnosis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018 North America is expected to account for the largest share of the global hepatitis test solution/diagnosis market. The large share of the North America region is mainly attributed to factors such as the developed healthcare systems in the US and Canada, rising adoption of advanced technologies, and the presence of a large number of leading national clinical laboratories.

The APAC region is projected to grow at the highest CAGR during the forecast period. The growth of the hepatitis test solution/diagnosis market in this region is driven by the widespread prevalence of hepatitis infections, increased healthcare spending by a larger population base, and modernization of healthcare infrastructure.

Nucleic Acid Tests (NATs) are relatively more expensive hepatitis diagnostic techniques than ELISA tests as the cost of NAT instruments is higher, in terms of outright purchases as well as rental agreements. NAT instruments require heavy investments, which most blood banks cannot afford. As a result, most end users opt for ELISA (serology) testing for hepatitis diagnosis, which limits the growth of the hepatitis testing market to a certain extent.

The key players in the hepatitis test solution/diagnosis market are Roche (Switzerland), Abbott Laboratories (US), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), Danaher (US), bioMérieux (France), and Grifols (Spain).

【レポートの目次】

Table of Contents

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Primary Data
2.1.1 Key Data From Primary Sources
2.1.2 Key Industry Insights
2.2 Secondary Data
2.3 Key Data From Secondary Sources
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.5.1 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Hepatitis Testing: Market Overview
4.2 Geographic Analysis: Hepatitis Testing Market, By Disease Type (2018)
4.3 Hepatitis Testing Market, By Technology, 2018 vs 2023
4.4 Hepatitis Testing Market, By End User, 2016–2023

5 Market Overview (Page No. – 30)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Burden of Hepatitis
5.1.1.2 Increasing Blood Transfusion and Donations
5.1.1.3 Benefits of POC Instruments & Kits
5.1.1.4 Awareness Initiatives
5.1.2 Restraints
5.1.2.1 High Cost of Nat
5.1.2.2 Lack of Mandate for Nat in Developing Countries
5.1.3 Opportunities
5.1.3.1 Emerging Markets

6 Hepatitis Testing Market, By Disease Type (Page No. – 35)
6.1 Introduction
6.2 Hepatitis B (HBV)
6.3 Hepatitis C (HCV)
6.4 Other Hepatitis Diseases

7 Hepatitis Testing Market, By Technology (Page No. – 41)
7.1 Introduction
7.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.3 Rapid Diagnostic Tests (RDT)
7.4 Polymerase Chain Reaction (PCR)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.6 Other Technologies

8 Hepatitis Testing Market, By End User (Page No. – 50)
8.1 Introduction
8.2 Hospital & Diagnostic Laboratories
8.3 Blood Banks
8.4 Other End Users

9 Hepatitis Testing Market, By Region (Page No. – 56)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Rest of Europe
9.4 Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 76)
10.1 Market Overview
10.2 Market Ranking Analysis, 2017
10.3 Competitive Situation and Trends
10.3.1 Collaborations, Agreements, and Partnerships
10.3.2 Product Launches and Approvals
10.3.3 Acquisitions

11 Company Profiles (Page No. – 80)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Abbott Laboratories, Inc.
11.2 Roche Diagnostics
11.3 Bio-Rad Laboratories
11.4 Siemens Healthineers
11.5 Diasorin
11.6 Qiagen
11.7 Danaher Corporation
11.8 Grifols
11.9 Biomérieux Sa
11.10 Ortho Clinical Diagnostics (A Part of the Carlyle Group)
11.11 Fujirebio, Inc. (A Part of Miraca Group)

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 105)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (69 Tables)

Table 1 Global Hepatitis Prevalence (Million People Approx.), 2015
Table 2 Increase in Voluntary Non-Remunerated Blood Donations and Total Blood Donations, 2008–2013
Table 3 Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 4 Hepatitis B Testing Market, By Region, 2016–2023 (USD Million)
Table 5 North America: Hepatitis B Testing Market, By Country, 2016–2023 (USD Million)
Table 6 Hepatitis C Testing Market, By Region, 2016–2023 (USD Million)
Table 7 North America: Hepatitis C Testing Market, By Country, 2016–2023 (USD Million)
Table 8 Hepatitis Testing Market for Other Diseases, By Region, 2016–2023 (USD Million)
Table 9 North America: Hepatitis Testing Market for Other Diseases, By Country, 2016–2023 (USD Million)
Table 10 Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 11 Hepatitis Testing Market for ELISA, By Region, 2016–2023 (USD Million)
Table 12 North America: Hepatitis Testing Market for ELISA, By Country, 2016–2023 (USD Million)
Table 13 Europe: Hepatitis Testing Market for ELISA, By Country, 2016–2023 (USD Million)
Table 14 Hepatitis Testing Market for Rapid Diagnostic Tests, By Region, 2016–2023 (USD Million)
Table 15 North America: Hepatitis Testing Market for Rapid Diagnostic Tests, By Country, 2016–2023 (USD Million)
Table 16 Europe: Hepatitis Testing Market for Rapid Diagnostic Tests, By Country, 2016–2023 (USD Million)
Table 17 Hepatitis Testing Market for PCR, By Region, 2016–2023 (USD Million)
Table 18 North America: Hepatitis Testing Market for PCR, By Country, 2016–2023 (USD Million)
Table 19 Europe: Hepatitis Testing Market for PCR, By Country, 2016–2023 (USD Million)
Table 20 Hepatitis Testing Market for Inaat, By Region, 2016–2023 (USD Million)
Table 21 North America: Hepatitis Testing Market for Inaat, By Country, 2016–2023 (USD Million)
Table 22 Europe: Hepatitis Testing Market for Inaat, By Country, 2016–2023 (USD Million)
Table 23 Hepatitis Testing Market for Other Technologies, By Region, 2016–2023 (USD Million)
Table 24 North America: Hepatitis Testing Market for Other Technologies, By Country, 2016–2023 (USD Million)
Table 25 Europe: Hepatitis Testing Market for Other Technologies, By Country, 2016–2023 (USD Million)
Table 26 Hepatitis Testing Market, By End User, 2016-2023 (USD Million)
Table 27 Hepatitis Testing Market for Hospital & Diagnostic Labs, By Region, 2016–2023 (USD Million)
Table 28 North America: Hepatitis Testing Market for Hospital & Diagnostic Labs, By Country, 2016–2023 (USD Million)
Table 29 Europe: Hepatitis Testing Market for Hospital & Diagnostic Labs, By Country, 2016–2023 (USD Million)
Table 30 Hepatitis Testing Market for Blood Banks, By Region, 2016–2023 (USD Million)
Table 31 North America: Hepatitis Testing Market for Blood Banks, By Country, 2016–2023 (USD Million)
Table 32 Europe: Hepatitis Testing Market for Blood Banks, By Country, 2016–2023 (USD Million)
Table 33 Hepatitis Testing Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 34 North America: Hepatitis Testing Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 35 Europe: Hepatitis Testing Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 36 Hepatitis Testing Market, By Region, 2016–2023 (USD Million)
Table 37 North America: Hepatitis Testing Market, By Country, 2016–2023 (USD Million)
Table 38 North America: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 39 North America: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 40 North America: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 41 HAV and HBV Vaccination Coverage: US (2014–2016)
Table 42 US: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 43 US: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 44 US: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 45 Canada: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 46 Canada: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 47 Canada: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 48 Europe: Hepatitis Testing Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 50 Europe: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 51 Europe: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 52 Germany: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 53 Germany: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 54 UK: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 55 UK: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 56 RoE: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 57 RoE: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 58 Estimated Prevalence of Chronic HBV and HCV: Asia Pacific
Table 59 Asia-Pacific: Cost Coverage for Diagnosis of Chronic Viral Hepatitis
Table 60 APAC: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 61 APAC: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 62 APAC: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 63 RoW: Hepatitis Testing Market, By Disease Type, 2016–2023 (USD Million)
Table 64 RoW: Hepatitis Testing Market, By Technology, 2016–2023 (USD Million)
Table 65 RoW: Hepatitis Testing Market, By End User, 2016–2023 (USD Million)
Table 66 Rank of Companies in the Hepatitis Testing Market, 2017
Table 67 Collaborations, Agreements, and Partnerships
Table 68 Product Launches and Approvals, 2015–2018
Table 69 Acquisitions, 2015-2018

List of Figures (29 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Hepatitis Testing Market, By Disease Type, 2018 vs 2023
Figure 7 Hepatitis Testing Market, By Technology, 2018 vs 2023
Figure 8 Hepatitis Testing Market, By End User, 2018 vs 2023
Figure 9 Geographical Snapshot of the Hepatitis Testing Market
Figure 10 High Burden of Hepatitis & Initiatives Taken By Government and Non-Government Organizations—Key Factors Driving Market Growth
Figure 11 Hepatitis B Segment to Account for the Largest Market Share in 2018
Figure 12 ELISA Will Continue to Dominate the Hepatitis Testing Market, By Technology, in 2023
Figure 13 Hospital & Diagnostic Laboratories to Account for the Largest Market Share in 2018
Figure 14 Hepatitis Testing Market: Drivers, Restraints, and Opportunities
Figure 15 Hepatitis Testing Market: Geographic Snapshot (2018)
Figure 16 North America: Market Snapshot
Figure 17 Reported Acute (New) Cases of Hepatitis C: US (2010-2016)
Figure 18 Asia Pacific: Hepatitis Testing Market Snapshot
Figure 19 Key Developments in the Hepatitis Testing Market Between 2015 and 2017
Figure 20 Abbott: Company Snapshot (2017)
Figure 21 Roche Diagnostics: Company Snapshot (2017)
Figure 22 Bio-Rad: Company Snapshot (2017)
Figure 23 Siemens AG: Company Snapshot (2017)
Figure 24 Diasorin: Company Snapshot (2017)
Figure 25 Qiagen: Company Snapshot (2017)
Figure 26 Danaher: Company Snapshot (2017)
Figure 27 Grifols: Company Snapshot (2017)
Figure 28 Biomérieux: Company Snapshot (2017)
Figure 29 Miraca: Company Snapshot (2017)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[肝炎検査ソリューション・診断の世界市場予測（～2023年）]についてメールでお問い合わせはこちら

◆関連調査資料◆

微生物迅速検査の世界市場予測（～2023年）
MD-6602 / MarketsandMarkets / 2018年9月12日 / MarketsandMarketsが発行した当調査レポートでは、微生物迅速検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、手法（培養、増殖力）分析、製品（自動微生物同定・ASTシステム、PCR、試薬）分析、用途（臨床診断、環境）分析、エンドユーザー（ラボ、病院、工業）分析、微生物迅速検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global rapid microbiology testing market is expected to USD 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%. Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing. This report broadly segments the rapid microbiology testing market into products, methods, applications, end users, and regions. Based on product, the global rapid microbiology testing market is segmented into instruments, reagents & kits,...

試験片有効性テストの世界市場予測（～2023年）
BT6295 / MarketsandMarkets / 2018年5月17日 / MarketsandMarketsが発行した当調査レポートでは、試験片有効性テストの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（試薬、コントロール、アッセイキット、消耗品）別分析、種類（実験室、POC検査）別分析、エンドユーザー別分析、地域別分析、試験片有効性テストの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global specimen validity testing market is projected to grow at 6.3% during the forecast period” The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.) “Specimen validity testing services are expected to grow...

感染症診断の世界市場予測（～2022年）：製品・サービス、疾患種類、技術、エンドユーザー
MAM-MD-3088 / MarketsandMarkets / 2018年4月16日 / MarketsandMarketsが発行した当調査レポートでは、感染症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス別分析、疾患種類別分析、技術別分析、エンドユーザー別分析、感染症診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.”The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market...

PoC/迅速診断の世界市場予測（～2022年）
MAM-MD-2702 / MarketsandMarkets / 2018年2月19日 / MarketsandMarketsが発行した当調査レポートでは、PoC/迅速診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、検査別分析、種類別分析、需要先別分析、地域別分析、PoC/迅速診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The point-of-care diagnostics market projected to grow at a CAGR of 10.0%.”The global point-of-care diagnostics market is projected to reach USD 38.13 billion by 2022 from USD 23.71 billion in 2017, at a CAGR of 10.0%. High prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and increasing inclination toward home healthcare across the globe are the factors expected to drive the market during the study period. However, the lack of alignment with definitive central lab methods, certain disadvantages of POC testing over central lab methods, and the reluctance among physicians to change existing diagnostic practices are...

特殊検査の世界市場予測（～2023年）：感染症、内分泌科、腫瘍学、毒物学、免疫学、神経学、遺伝子検査
MAM-MD-5930 / MarketsandMarkets / 2018年1月25日 / MarketsandMarketsが発行した当調査レポートでは、特殊検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、地域別分析、特殊検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Esoteric testing market projected to grow at a CAGR of 11.6%”The esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, and increasing government funding for the research and development of innovative esoteric tests. Moreover, the introduction of a new range of condition-specific markers and tests, with...

臨床検査サービスの世界市場予測（～2022年）
MAM-MD-5847 / MarketsandMarkets / 2017年12月21日 / MarketsandMarketsが発行した当調査レポートでは、臨床検査サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、専門別分析、プロバイダー別分析、地域別分析、臨床検査サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Clinical laboratory services market projected to grow at a CAGR of 5.2% The clinical laboratory services market is projected to reach USD 146.14 billion by 2022 from USD 113.44 billion in 2017, at a CAGR of 5.2%. The increasing global burden of target diseases, advancements in clinical diagnostic techniques, and rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures are the major factors driving the demand for clinical laboratory services market. Factors such as the pricing pressure faced by healthcare payers and providers and the procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures are...

ラテラルフローアッセイの世界市場予測（～2022年）
MAM-MD4158 / MarketsandMarkets / 2017年8月14日 / MarketsandMarketsが発行した当調査レポートでは、ラテラルフローアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、製品別分析、用途別分析、技術別分析、需要先別分析、ラテラルフローアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global lateral flow assay market is projected to reach USD 8.24 Billion by 2022 from USD 5.55 Billion in 2017, at a CAGR of 8.2%. The growth of this market is majorly driven by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices. The report analyzes the global lateral flow assay market by product, application, technique, end user, and region. On the basis of product, the kits & reagents segment accounted for the largest share in 2016, owing to the increasing application of...

大麻検査の世界市場予測（～2021）
BT5107 / MarketsandMarkets / 2017年3月22日 / 当調査レポートでは、大麻検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品別分析、サービス別分析、需要先別分析、地域別分析、大麻検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cannabis testing market is expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016, at a CAGR of 11.5% during the forecast period (2016–2021). The growth in this market is mainly driven by factors such as legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories (specifically in the U.S.); growing adoption of LIMS in cannabis testing laboratories; and increasing awareness through conferences, symposia, and workshops. On the other hand, the high cost of analytical instruments, presence of alternative technologies, and dearth of skilled professionals are some of the major factors...

女性医療診断の世界市場予測（～2021）：出生前検査、ダウン症候群検査、HPV検査、受胎能試験、妊娠テスト、尿路感染症検査、骨粗鬆症検査、乳がん検査、子宮頸がん検査、卵巣がん検査
MAM-MD-4774 / MarketsandMarkets / 2016年11月25日 / 当調査レポートでは、女性医療診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、用途別分析、需要先別分析、地域別分析、女性医療診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. Moreover, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for...

感染症診断・検査製品の世界市場：感染症検査試薬、検査キット、診断機器、アナライザー
MAM-MD-3088 / MarketsandMarkets / 2015年1月8日 / 当調査レポートでは、感染症診断・検査製品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、製品別分析、用途別分析、技術別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。...Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion’s share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases. On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG),...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆